Abstract. Squamous cell carcinoma antigen (SCCA) is a useful tumor marker for diagnosis and management of squamous cell carcinoma. Recent reports have shown that SCCA can influence the invasion or metastasis of cancer cells. However, it remained unclear how SCCA acts to mediate these biological functions. To solve this question, at first, SCCA1-and SCCA2-glutathione S-transferase fusion protein were used to purify a protein which binds to SCCA1 or SCCA2, and the combined protein was identified by proteomic analysis. Secondly, immunocytochemical and immunohistochemical analyses were performed to investigate the localization of this protein. Third, Western blotting was performed to analyze the expression levels of this protein in keratinocytes and six kinds of uterine squamous cell carcinoma cell lines. Both SCCA1 and SCCA2 molecules bind to the cytoplasmic protein, which was identified to be carbonyl reductase (CR). The immunostaining analyses revealed that CR is located in the cytoplasm of keratinocytes and the normal squamous epithelial cells of the uterine cervix as well as SCCA1 and SCCA2. The CR expression levels in six kinds of squamous cell carcinoma cell lines were lower compared to those in keratinocytes. In conclusion, CR binds to SCCA1 and SCCA2 and they are co-located in the same layer of the squamous epithelium, suggesting that CR may collaborate with SCCA1 and SCCA2 to mediate cancer behavior such as invasion or metastasis.
Introduction
Squamous cell carcinoma antigen (SCCA) was first discovered in the uterine cervical squamous cell carcinoma by Kato and Torigoe (1) , and was widely used as a useful tumor marker for squamous cell carcinoma of various organs (2) (3) (4) . Recent molecular studies have revealed that SCCA is encoded by two highly homologous genes, SCCA1 and SCCA2, at 18q21.3 locus (5, 6) . Interestingly, both SCCA1 and SCCA2 belong to the serine proteinase inhibitor (serpin) family (5, 7) . SCCA1 inhibits both serine proteinase and cysteine proteinase, while SCCA2 inhibits serine proteinase, chymase and cathepsin G (8) (9) (10) (11) . These facts made us speculate that SCCAs may have important biological functions in squamous cell carcinoma. In fact, our previous studies have shown that both SCCA1 and SCCA2 showed some biological functions: SCCAs suppress the apoptotic cell death induced by natural killer cells, an antineoplastic agent, and irradiation (12, 13) ; SCCAs stimulate matrix metalloproteinase-9 production (14); suppressed SCCA2 promotes cancer cell invasion and migration in the decrease of E-cadherin expression (15) . These results suggest the possibility that both SCCA1 and SCCA2 may be involved in the regulation of cancer cell behavior and the malignant potential. However, it was not fully understood what molecules bind to SCCAs or how SCCAs regulate such biological pathways and functions. Therefore, we investigated the molecules, which bind to SCCAs using molecular methods.
Materials and methods
Cell culture. The human uterine cervical SCC cell lines, BOKU, ME-180, SiHa, SKG I, SKG II and SKG IIIa, and the human normal keratinocyte cell line, PHK16-0b were used. SKG IIIa was kindly provided by Dr S. Nozawa (Keio University School of Medicine, Tokyo, Japan), and BOKU, SKG I, SKG II, ME-180 and keratinocyte PHK16-0b were purchased from Health Science Research Resources Bank (Osaka, Japan). BOKU, SKG I, SKG II and SKG IIIa were cultured in Ham's F 12 (Sigma, St. Louis, MO, USA) supplemented with 10% heat inactivated fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin. SiHa and ME-180 were cultured in Eagle's minimal essential medium (Sigma), and PHK16-0b was cultured in defined keratinocyte-SFM with growth supplement (Invitrogen, Carlsbad, CA, USA). These cell lines were cultured at 37˚C in a humidified 5% CO 2 incubator.
Binding of cellular proteins to GST fusion protein.
A glutathione S-transferase (GST) fusion protein construct of SCCA1, and SCCA2 cDNA were kindly provided by Gary A. Silverman (Harvard University, Boston, MA, USA). These fusion proteins are named GST-SCCA1 and GST-SCCA2, respectively. Their purification procedures were described previously (10) . The in vitro binding study was performed as described previously (16) . In brief, 1x10 8 of keratinocyte PHK16-0b was resuspended in the cell lysis buffer containing 20 mM Tris-HCl pH 8.0, 1% NP-40, 2 mM EDTA, and 60 mM NaCl. Mild sonication was performed and unsolubilized materials were removed by centrifugation at 15,000 rpm for 10 min at 4˚C. The cell lysate was mixed with glutathione sepharose 4B beads (GE Healthcare UK Ltd., Little Chalfont, UK) -GST fusion proteins (GST, GST-SCCA1, and GST-SCCA2) for 2 h at 4˚C and then mixed with 100 μl of a 1:1 slurry of glutathione sepharose 4B (GE Healthcare UK Ltd.). After incubation for 2 h at 4˚C, the beads were washed 8 times in the cell lysis buffer and the binding proteins were eluted with Laemmli's sample buffer for 10 min at 100˚C. The samples were fractionated by 10% SDS-PAGE and each protein was fixed and stained on the gel with 30% methanol, 10% acetic acid, and 0.1% Coomassie brilliant blue R-250 (CBB). The gel was destained with 30% methanol and 10% acetic acid until the stain of background was clear and colorless. The different protein bands between GST (the control), GST-SCCA1, and GST-SCCA2 were excised from the gels.
In-gel digestion and peptide mass fingerprinting. The CBB dye in the excised gels was removed by rinsing twice in 60% methanol, 50 mM ammonium bicarbonate, 5 mM DTT for 15 min and twice in 50% acetonitrile, 50 mM ammonium bicarbonate, 5 mM DTT for 7 min. The gel piece was dehydrated in 100% acetonitrile and then rehydrated with an in-gel digestion reagent containing 10 μg/ml sequencing grade trypsin (Promega, Madison, WI, USA) in 30% acetnitrile, 50 mM ammonium bicarbonate, 5 mM DTT. The in-gel digestion was performed overnight at 30˚C. After the in-gel digestion, 1 μl of the reaction mixture was removed and 1 μl of the matrix solution (10 mg/ml ·-cyano-4-hydroxycinnamic acid in 50% acetonitrile, 40% methanol, 0.1% TFA) was added on a MALDI target plate. MALDI-TOF MS for peptide mass fingerprinting was performed on a Shimadzu Biotech AXIMA-CFR mass spectrometer (Kyoto, Japan) in reflection mode. The MS-Fit database search engine of the Protein Prospector web site was used for protein identification.
Preparation of anti-SCCA binding protein polyclonal antibody.
The peptide, sequence CHQKEGWPSSAYG, was synthesized and conjugated to keyhole limpet hemocyanin, via the aminoterminal cystein of the synthetic peptide, which is not present in the deduced amino acid sequence. New Zealand white rabbits were injected three times with the antigen. In order to assess the effectiveness of the immunization, an enzymelinked immunosorbent assay with free peptide-coated microtiter plates was performed to measure the antibody titer. The rabbits were bled 10 days after the last injection and antiserum was collected and stored at 4˚C. All animal experiments were carried out in accordance with the institutional guidelines.
Immunoprecipitation and Western blot analysis. Cultured 1x10 8 of keratinocytes were resuspended in 1 ml of lysis buffer (50 mM Tris, 0.1% SDS, 0.5% Na Deoxycholate, 150 mM NaCl and 1% Triton X-100), mild sonication was performed, and unsolubilized materials were removed by centrifugation at 15,000 rpm for 10 min at 4˚C. The cell lysate was mixed with 60 μl of a 50% of protein A-sepharose beads (Kirkegaard and Perry Laboratories, Gaithersburg MD, USA) for 1 h at 4˚C. After centrifugation at 14,000 x g, the supernatant was incubated with anti-carbonyl reductase (CR) rabbit serum or normal rabbit serum as the negative control. The antigenantibody complexes were precipitated by incubating for 3 h at 4˚C with 60 μl of 50% of immobilized protein A-sepharose beads. The beads were boiled in 50 μl of Laemmli's sample buffer for 2 min. The eluted proteins were analyzed by 10% of SDS-polyacrylamide gel. After SDS-PAGE was completed, proteins were transferred to the polyvinylidene difluoride membrane (ATTO, Tokyo, Japan) with semi-dry type blotting system. The transferred membranes were stained by immunochemical technique consisted of following procedure: after blocking the membrane with the blocking solution (5% skimmed milk with 0.1% Tween-20 dissolved in Tris-buffered saline, pH 7.5), the blotted membrane was incubated with the anti-SCCA monoclonal antibody, Mab 13, as the first antibody, which was diluted in the blocking solution. Then, the membrane was incubated with the peroxidase conjugated second antibody diluted in the blocking solution. Finally, ECL-Western blotting detection system (GE Healthcare UK Ltd.) was applied according to the manufacturer's protocol and then the membranes were exposed to the hyperfilm-ECL (GE Healthcare UK Ltd.).
Immunocytochemistry and immunohistochemistry.
The reactivity to the cultured keratinocyte PHK16-0b and human normal squamous epithelium from uterine cervix was assessed by immunostaining technique. Keratinocytes PHK16-0b were cultured on the chamber slides (BD Falcon, Franklin Lakes, USA), were fixed with 4% paraformaldehyde for 1 h at room temperature and washed with PBS and the human specimens were fixed in 10% buffered formalin and embedded in paraffin. All paraffin blocks were cut into 3 μm-thick sections and the sections were de-paraffinized in xylenes and rehydrated in ethanol, the samples were washed with cold PBS. The streptavidin-biotin-peroxidase complex technique was used for immunostaining as follows: endogeneous peroxidase was blocked by incubating in 0.5% hydrogen peroxide in methanol for 50 min at room temperature, then, the cells were washed three times with cold PBS. After incubation with 10% normal rabbit serum (SCCA) or 10% normal goat serum (CR) to block nonspecific binding, the specimens were sequentially incubated with the primary antibody against SCCA1 and SCCA2 (both were kindly provided by Gary A. Silverman) or anti-CR rabbit serum at 4˚C overnight. After the incubation, they were rinsed in cold PBS and incubated for 30 min at room temperature with biotinylated anti-mouse IgG+IgA+IgM (SCCA) or anti-rabbit IgG+IgA+IgM (CR) using with HISTFINE SAB-PO kit (Nichirei, Tokyo, Japan) followed by streptavidin-biotin-peroxidase complex. The reaction was revealed by adding diaminobenzidinetetrahydrocholoride chromogen mixture (Sigma). After hematoxylin couterstaining, slides were permanently mounted and analyzed for the presence and distribution of the immunostaining.
SDS-PAGE and Western blot analysis.
Cultured keratinocytes and six kinds of squamous cell carcinoma cell lines were resuspended in Laemmli's sample buffer and mild sonication was performed. These samples were boiled for 10 min and unsolubilized materials were removed by centrifugation at 15,000 rpm for 10 min at 4˚C. Total proteins (150 μg) were electrophoresed on 10% SDS-polyacrylamide gels. The transfer and blocking procedures were described above. After the blocking procedure, the blotted membrane was incubated with the anti-carbonyl reductase rabbit serum, as the first antibody, which was diluted in the blocking solution. Then, the membrane was incubated with the peroxidase conjugated anti-rabbit goat antibody diluted in the blocking solution. Finally, ECL-Western blotting detection system (GE Healthcare UK Ltd.) was applied according to the manufacturer's protocol and then the membranes were exposed to the hyperfilm-ECL (GE Healthcare UK Ltd.).
Results

Detection of proteins on SDS-polyacrylamide gels.
To investigate the possibility of protein-protein interactions of SCCA1 or SCCA2 molecules with the intracellular proteins, affinity purification was carried out using GST-SCCA1 or GST-SCCA2, respectively. The cell lysate was incubated with GST-SCCA1 and GST-SCCA2 and combined proteins were recovered by glutathione agarose. Protein bands were visualized on the SDS-polyacrylamide gels after CBB staining (Fig. 1) . The two bands were identified by peptide mass fingerprinting. Each band provided good amino acid sequences with LC-MS/MS. These proteins were identified as SCCA and CR.
Immunoprecipitation and Western blot analysis. To confirm that SCCA binds to CR, immunoprecipitation followed by Western blotting using anti-SCCA monoclonal antibody was carried out. The major band with molecular weights of 45 kDa was revealed the full length of SCCA. Small molecular weights of 30 kDa and 15 kDa were confirmed the degraded products of SCCA (Fig. 2) . This result suggests that SCCA binds to CR.
Immunocytochemistry and immnohistochemistry. CR was located in the cytoplasm as well as SCCA1 and SCCA2 (Fig. 3) . Immunohistochemistry revealed that SCCA1 and SCCA2 were located in the cytoplasm of the normal squamous epithelial layer (Fig. 4) . CR was similarly located in the same normal squamous epithelial layer (Fig. 4) .
Western blot analysis for CR expression in the cultured cell lines.
To investigate the expression levels of CR in keratinocytes and six kinds of squamous cell carcinoma cell lines, Western blot analysis was carried out using anti-CR rabbit serum. Western blot analysis showed that CR expression in six kinds of squamous cell carcinoma cell lines are lower compared to that in keratinocytes (Fig. 5) . 
Discussion
The present study showed that there is a protein in the cytosol that both SCCA1 and SCCA2 are binding in normal keratinocytes, and that the protein was identified as CR. CR is a NADPH-dependent, mostly monometric, cytosolic enzyme with broad substrate specificity for carbonyl compounds (17, 18) . It has been therefore extensively studied in relation to its ability to reduce a variety of carbonyl conpounds; the antitumor anthracycline antibiotics, daunorubicin (19) and doxorubicin, and prostaglandins (20) . Prostaglandins, especially prostaglandin E2 (PGE2), play important roles in modulating tumor growth and metastasis in many kinds of human tumors. PGE2 promotes development and progression of cancer cells (21) , by promoting angiogenesis through enhancement of vascular endothelial growth factor expression (22, 23) , inhibition of apoptosis (24) , and regulation of cytokines (25) . Therefore, it is speculated that CR may play important roles in suppression of tumor growth and metastasis by inactivation of PGE2. It was recently reported that CR suppresses tumor growth and metastatic behavior (26) . However, the mechanisms by which CR acts in cancer cell proliferation and malignant behavior is not fully understood.
Our previous study showed that suppression of SCCA2 expression promoted cell invasion and cell migration with decreased expression of E-cadherin, and that blockage of Ecadherin function by anti E-cadherin antibody treatment inhibited cell invasion and cell migration (15) . Our recent study also showed that there was a significant relationship in expression patterns between SCCA2 and E-cadherin in squamous cell carcinoma tissues (27) . Furthermore, decreased SCCA2 expression, as well as decreased Ecadherin expression, was closely associated with high incidence of lymph node metastasis (27) . These findings strongly suggest that SCCA regulates cancer cell behaviors through alternation in E-cadherin expression. Interestingly, recent report showed that the cultured cancer cells with decreased CR expression showed high incidence of metastasis (26) . Our present study shows that SCCAs and CR co-located in the cytoplasm in the normal squamous epithelial layer. Furthermore, CR expression levels of six kinds of squamous cell carcinoma cell lines were lower compared to that in keratinocytes. These findings strongly suggest a possibility that CR may collaborate with SCCA1 and SCCA2 to mediate malignant behavior such as invasion or metastasis by controlling E-cadherin expression. This hypothesis also leads us to think that SCCAs and CR may be key molecules concerned with epithelial mesenchymal transition. However, it is unclear how CR modifies the function of SCCAs and further investigation is needed regarding the mechanisms by which CR modulates malignant behavior.
The present study may provide new insight into understanding the mechanism for malignant behavior of cancer cells. It may be possible to control cancer cell invasion and metastasis by molecular targeting therapy with control of CR and SCCA in near future.
